Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Broker running a stock scam is very beneficial..https://brokercheck.finra.org/individual/summary/4231884
Good volume too !!
Did these guys convert from Christianity to Judaism?...Easter...to...Passover...excuses!!!!!! They must have made the conversion in April between the holidays. Sammy Davis Jr. would be so proud!!!!!
Trust me mike, JB isn't Jeff Bezos any more than I am LeBron James. And Seven Tweets Entertainment isn't Amazon any more than the corner liquor store is Tesla.
That is what they said about some of my last 5 picks that made 20,000% Gains.
Holding say a Nickle is possible with the right deals. Novartis has about 3 Billion shares issued and has 200 week moving average around $100/share
Amazon started in a Garage in 1994 with a website, and a plan, most thought was nuts, and no money left, just credit card to buy the first book they sold, and folks would laugh at that website today. Fed Exp start up business plan also sounded nuts....
How about Seven Tweets Entertainment?
What are the odds this doesn't go down in the end???? I'm sure you know the drill Mike. Lots of PR's and nothing official. Lots of delays until the next bullshit commences.
Hmm, so the CEO PRs an 8 Mill dollar revenue deal with an NYSE Listed Monster, Lions Gate, that is just 2 of many movies that had no listed asset value in the financials, JB turned into a huge bankable revenue, cash flow deal, and you post what-a-bout "How 'bout CEO excuses?"
Seriously?
Banjo50, this fraudulent scam isn't worth more than...$0.0001...https://www.sec.gov/files/litigation/complaints/2022/comp25413.pdf
I can't picture you socializing at the Bourbon Club, or anywhere, for that matter.
More like a three ring circus.
Best one yet...puravida straightening me out,
yup, not one smidgen of truth in my response to his post..just me fabricating things about real honest individuals:
puravida19
Re: shoondale post# 85715
Friday, February 21, 2020 4:03:34 AM
Post# 85718 of 104404
There's not a smidgen of Truth in your response. JV happened; solid contract; there's nothing on record saying otherwise.
shoondale
Re: puravida19 post# 85714
Friday, February 21, 2020 2:05:10 AM
Post# 85715 of 104404
"That's a bunch of malarkey.
Two weeks since Squires issued the Shareholder letter. That's not communicating?"
"Hartigan posts on LinkedIn and Twitter."
"Balchin did an update a few months ago."
"It's easy to criticize the past."
"But why bother when you can make falsehoods up? That is so lazy and uncool."
"Here is what we should talk about because this is QMC TODAY in the QDSC area:
1. Assam is building QDSC Facilities at no cost to QMC OR Amtronics India. $82 million."
"2. Assam pays QMC licensing fees and royalties, equipment, training and consultant fees. $7 to $10 million."
"3. QMC retains all it's IP rights and gains rights to any IP developed."
"4. QMC intends to duplicate this deal elsewhere many times."
puravida19
Re: hookem post# 85711
Friday, February 21, 2020 12:59:14 AM
Post# 85714 of 104405
That's a bunch of malarkey.
Two weeks since Squires issued the Shareholder letter. That's not communicating?
Hartigan posts on LinkedIn and Twitter.
Balchin did an update a few months ago.
It's easy to criticize the past.
But why bother when you can make falsehoods up? That is so lazy and uncool.
Here is what we should talk about because this is QMC TODAY in the QDSC area:
1. Assam is building QDSC Facilities at no cost to QMC OR Amtronics India. $82 million.
2. Assam pays QMC licensing fees and royalties, equipment, training and consultant fees. $7 to $10 million.
3. QMC retains all it's IP rights and gains rights to any IP developed.
4. QMC intends to duplicate this deal elsewhere many times.
You'll really appreciate puravida straightening out kurt:
puravida19
Re: puravida19 post# 90589
Monday, June 08, 2020 9:09:07 AM
Post# 90594 of 104403
This lawsuit is big!
So far so good. I admit it is still to be decided.
But I question if K&L would let this go to discovery.
We are not just talking about $100M, but K&L Execs
have to decide if they want to risk Jail like Bernie Maddow
and how much the loss to their reputation will cost K&L in
the long run. Those are reasons to make a deal.
Jail is possible if the IRS and the SEC come around
after the case, too. (EDIT - AND THE FINES!!!)
Based on how poorly they have done
up to now, they have to question whether they can beat
Minns and Arnett.
puravida19
Re: Kurt_Banoffee post# 90587
Monday, June 08, 2020 8:46:34 AM
Post# 90589 of 104403
This will be a landmark case for small companies abused by predatory lenders using predatory lawyers.
"whatever sum the jury finds is adequate punishment to prevent this type of conduct in the future when a billion-dollar elitist law firm considers...
...trampling on a client without adequate resources to defend themselves.
...Predatory lenders prey on financial difficulties.
...A predatory law firm can prey on the concept of justice itself."
Laughable blast from the past:
Posted by: Solar_Express
In reply to: Long-vestor who wrote msg# 66916
Date: 11/12/2018 10:10:48 PM
Post #: 66,920 of 104,401
Long-v and hookum are welcome to your opinion however I totally disagree with your assertion about the future of QTMM which looks quite bright IMO.
1) They are off the Pink sheets on the OTC-QB and Current with Filings.
2) They are counter suing the predator lenders and their legal team for 100M.
3) They have in the 10K Entered into a licensing agreement to establish quantum dot production and solar film production in Asia Pg 6. Could be India or China we're waiting for further details.
4) Game Changer No 1 QMC Announces "Volume" Perovskite QD Process making QD Solar Competitive with Silicon CIGS in regards to efficiency and Roll to Roll Process.
5) Game Changer No 2 Quantum Materials Corp Achieves Industry Leading 91% Rec2020 Color Gamut Performance with Remote Phosphor "On-chip" Quantum Dot Technology. This is 20% higher than Nanosys or Samsung currently for LCD's as a "Drop In Solution". Also this is transforming LED lighting and a year testing with NO Degradation to boot.
6) It's up to Steve to disclose more details about OEM's. At this time, QMC is working with a number of LED component companies, display manufacturers and chemical companies to bring this next-generation technology to market as a superior and lower cost solution to the current industry practice of incorporating quantum dot infused films into LCD displays to increase color gamut and improve viewer experience.
7) They are forecasting Revenue early in 2019.
Posted by: Long-vestor
In reply to: BigE1960 who wrote msg# 66856
Date: 11/12/2018 07:39:11 PM
Post #: 66,916 of 104,401
"How the market has reacted to QMC?"
It's called a front run and dump. Exactly what's happened every time good ol'Stevy puts out hype news.
Toxic convertibles dumping as hard as they can, proof in this pudding is; the daily dumping into the low bidders.
It couldn't be more clear except, anybody turning a blind eye to reality.
SO YA, I see being honest doesn't make you popular whatsoever.
Steal, doesn't the SEC frown upon corporate officers posting on the internet and pumping up their own stock?
This is dirty. I think you are right steal. Legitimate Businessmen don't act this way.
5 months and 11 days. And the perp was long behind bars, with that post and others, at that point. That is the important issue. One can only hope megola is being accurate. In any event, his association with megola scares the bejesus out of me.
posted on that company in 6 months
ONLY reason I went on GEVI was we all know Conboy reads message boards as he did with ECOB..the one he bankrupt and ruin many investors . NOW doing exact same at GEVI. FACT no board people there have any real answers to any solid financial questions...they merely YELL basher and thats it.
I DON'T BELIEVE any message board poster can affect a stock whatsoever.
But megola shares a shareholder in common with nwgc. nwgc appeared that way too. Next thing, the perp was in jail and the shareholder megola shares in common with nwgc was praising it right along as the stock collapsed. He still presently praises it as the perp is about to get out of lockout. That shareholder now praises megola. What conclusion are we to draw about this association? Shouldn't this concern us?
What are the chances the corporate officers will be serving jail time in the future?
What makes you think this is not another fraudulent scam?
Another Green Day ??
Cool……
$$ UEEC $$
CHARLIESAN
Re: rodman post# 12756
Tuesday, December 19, 2023 12:11:04 PM
Post# 12757 of 13460
"Yes, I am a loser; about 800K in this position; and I own a significant amount of shares; in the 7 digits. You must be braindead to think that this CEO and management team do not deserve criticism in their inability to get a PMA filed. They need prodded; pushed; criticized; by any means necessary to accomplish their duties. So you will stand by another year and watch paint dry? Their communication and actions are a travesty and reek of incompetence. Calling it like it is. If you cannot see this you might look in the mirror before denigrating others."
Magnify it and check out the frames. It is from the night of the filming at the Bourbon Room., Most of these "stock photos" were taken the night of the filming at the Bourbon Room on cell phones.
"Looks like another day of deception by JB on behalf of SAPX"
"I think Ecomike is right"
Quite a few disappeared after the run up to .0014. I don't see those same posters returning and buying back in with the price dropping as much as 50% or more. Maybe they know the drill?
How come you never see any of these 6700+ people enthused about this POS fraudulent Ponzi Scheme, buying into it, and posting on this board?
Answer: you PM them you will follow them if they follow you because you think it makes you look like an authority. Maybe to the United Health Fraud Ponzi Scheme operators who give you shares to bullshit suckers. But who else is fooled? Actually, you are quite useful to these followers. They see where you go and know what to stay away from because you never know what you are talking about. For instance, this POS fraudulent scam has gone down over 90% in less than 5 years while you rave about it. Go ahead and click on 5 yrs in the linked chart:
https://finance.yahoo.com/quote/UEEC
They follow you and distance themselves. The price action over the last 5 years, and lack of interest, speaks volumes about why you are followed. These followers know you as well as I do.
UEEC--Still a fan of me, I see.
Don't worry I have 6700+ of them on I-HUB.
Toodles.
fool
noun
a person who acts unwisely or imprudently; a silly person.
"I spend more on a Friday night."
"FIRST CLAIM FOR RELIEF
Violations of Exchange Act Section IO(b) and Rule 10b-5 Thereunder
(UHP and Beplate)
SECOND CLAIM FOR RELIEF
Violations of Exchange Act Section I0(b) and Rules IOb-S(a) and (c) Thereunder
(Schiliro)
THIRD CLAIM FOR RELIEF
Aiding and Abetting Violations of Exchange Act Section lO(b) and Rule 10b-5(b)
(Schiliro)
FOURTH CLAIM FOR RELIEF
Violations of Securities Act Section 17(a)
(All Defendants)
FIFTH CLAIM FOR RELIEF
Violations of Exchange Act Section 13(a), 13(b)(2)(A) and 13(b)(2)(B)
of the Exchange Act and Rules 12b-20, 13a-1 and 13a-13 Thereunder
(UHP)
SIXTH CLAIM FOR RELIEF
Aiding and Abetting Violations of Exchange Act Section 13(a),
13(b)(2)(A), 13(b)2)B), and Rules 12b-20, 13a-1 and 13a-13
(Beplate and Schiliro)
SEVENTH CLAIM FOR RELIEF
Violation of Section 13(b)(5) of the Exchange Act and Exchange Act Rule 13b2-1
(Beplate and Schiliro)
EIGHTH CLAIM FOR RELIEF
Violations of Exchange Act Section 13(a) and Rule 13a-14 Thereunder
(Beplate)
NINTH CLAIM FOR RELIEF
Violations of Rule 13b2-2 of the Exchange Act
(Beplate and Schiliro)
TENTH CLAIM FOR RELIEF
Violations of Sarbanes-Oxley Act Section 304(a)
(Beplate)
ELEVENTH CLAIM FOR RELIEF
Violations of Exchange Act Section 16(a) and Rule 16a-3 Thereunder
(Beplate)"
UEEC-another bald-face lie from 🖕Sporty🖕..."As you, yourself stated, "Do not be hindered by the truth, it gets in the way of bashing."", You aren't quoting me, You are just plain pathological in your fabrications. Obviously, you can't cite a post containing that. But hey, we can't expect anything else from you and your cronies involved in this sociopathic scam based on a fraudulent company with a hyped fictitious magic bandage..
Actually, you addressed me and I responded. But don't let that get in the way of your narrative. The truth never has and evidently never will. And it is more jaw dropping, amazed, utter bemusement at your lack of common sense and rejection of logic rather than being a fan in the conventional sense. By the way, have you forgotten all the "fan club" PM's I received from someone with a little doggie that wears a hat?
"No one has been ghosted by me."
"In summation, I am fascinated by your continued references to me, I can tell you are a HUGE fan. Maybe when this is all over, I will hold one certificate share of UEEC stock, autograph it and mail it to you, to commemorate our stellar relationship. Given that I believe that UEEC stock will be somewhere between $5.00--$10.00 ++, and the cost of 1 forever postage stamp, this gift will cost me $5.75--$10.75, but you will need it."
I've always maintained there is a long history of FDA submissions to the contrary of what you are stating. Check my posts. In fact, this bullshit has been going on since 2017. What is missing is a copy of the actual FDA determination and actual reasons for rejection. I wonder why United Health Fraud never divulges that?
"no FDA submissions"
""FDA Selects HemoStyp ® for CtQ Pilot Program
Henderson, Nevada – December 4, 2017 –United Health Products, Inc. (UHP) (OTC: UEEC), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that it is proceeding with its application for HemoStyp under the FDA’s new and innovative CtQ Pilot Program. The FDA selected UHP’s HemoStyp as only one of nine participants for the program. UHP management has scheduled its first face-to-face meeting with FDA experts for January 17, 2018 to provide the agency with whatever information it needs to advance the application for premarket approval (PMA).
The FDA has stated that it intends to work collaboratively with pilot program participants during the review of their PMA submission to define characteristics of the device that are critical to product quality, and how these characteristics are controlled in design and manufacturing prior to the postmarket inspection. For pilot program participants, the FDA would forego conducting the standard PMA preapproval inspection, and a postmarket inspection focusing on the PMA applicant’s implementation of the critical to quality characteristics would be conducted instead.
The CtQ Pilot Program was created to identify products that have a chemical makeup of demonstrated safe interaction with the body –as evidenced by years of prior product usage and studies-- to be approved for Class III internal surgical use. The program’s intent is to allow products that have demonstrated repeated safe interaction to enter the market in a more efficient manner. This application will run simultaneously with the company’s prior Class II application for expanded indication. The market for 2017 internal surgical market for hemostatic products is estimated at in excess of seven billion dollars, and is expected to grow at 7.1% over the next few years, to reach more than $8.3 billion by 2022. (http://industryarc.com/Report/15189/hemostats-market.html)
Concurrent with its CtQ Pilot Program participation, UHP reaffirms that its current Class II application – Expanded Indication submission with the US FDA-- continues to progress, and is in an advanced stage of review
About Premarket Approval Application Critical to Quality (PMA CtQ) Pilot Program
Top-quality medical devices help the FDA better protect and promote public health. And one of the top priorities for FDA’s medical devices center is a focus on quality.
More specifically, the FDA is working with stakeholders—industry, health care providers, patients, payers, and investors—to build a strong Case for Quality.
This program allows the FDA to identify device manufacturers that consistently produce high-quality devices. By doing so, we can better focus our resources helping other manufacturers raise their level of quality. This program also helps the FDA identify and promote practices that support consistent quality manufacturing, and align our regulatory, enforcement, compliance approaches with those practices.
The FDA launched the Case for Quality in 2011 following an in-depth review of device quality data and feedback from both FDA and industry stakeholders. The FDA’s analysis flagged certain widespread or common manufacturing risks that impact product quality. The review also showed manufacturers that focus on and manage those risks often become more productive, receiving fewer complaints, needing to open fewer CAPAs and investigations, and having lower quality-related product costs than their competitors.
In simple terms, the review identified that an investment in quality has long-term payoffs."
To think I always thought of Shangri-La as mythical.
Wow that’s a lot to grasp from me saying Sporty I can’t get you on private
.. you still avoided my question
and you really need to dedicate your time to something better